{"id":229102,"title":"Guidelines for Preparation of New Drug Submissions for Products Used for Estrogen-Progestin Replacement Therapy in Menopause (HRT) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T00:18:22.259000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false","snippet":"Guidelines for Preparation of New Drug Submissions for Products Used for Estrogen-Progestin Replacement Therapy in Menopause (HRT) - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating it. You can use it for research or…","rawSnapshotUrl":"/api/snapshots/raw/229102","browseUrl":"https://replay.healtharchive.ca/job-1/20250419001822/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false#ha_snapshot=229102","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}